New diabetes clinical trial: Long-Term Effects of Semaglutide on Body Composition and Performance in Running
Published on: 2026-10-15T04:00:00Z Conditions : Caloric Restriction; Body Composition; Performance Interventions : Drug: Semaglutide (SEMA); Drug: Placebo Sponsors : Morten Hostrup, PhD Not yet recruiting https://ift.tt/s7Hlr5R